agilon health (NYSE:AGL) Price Target Cut to $8.00 by Analysts at Royal Bank of Canada
agilon health (NYSE:AGL – Free Report) had its target price reduced by Royal Bank of Canada from $11.00 to $8.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has an outperform rating on the stock. AGL has been the subject of a number of other research […]
More Stories
TXNM Energy (NYSE:TXNM) versus Avangrid (NYSE:AGR) Head to Head Review
TXNM Energy (NYSE:TXNM – Get Free Report) and Avangrid (NYSE:AGR – Get Free Report) are both oils/energy companies, but which...
Head-To-Head Analysis: Oak Valley Bancorp (NASDAQ:OVLY) vs. Signature Bank (NASDAQ:SBNY)
Insider and Institutional Ownership 30.9% of Oak Valley Bancorp shares are held by institutional investors. Comparatively, 11.1% of Signature Bank...
ATP Oil & Gas (OTCMKTS:ATPAQ) vs. Matador Resources (NYSE:MTDR) Financial Survey
ATP Oil & Gas (OTCMKTS:ATPAQ – Get Free Report) and Matador Resources (NYSE:MTDR – Get Free Report) are both mining...
Head to Head Comparison: JATT Acquisition (NYSE:JATT) & Editas Medicine (NASDAQ:EDIT)
JATT Acquisition (NYSE:JATT – Get Free Report) and Editas Medicine (NASDAQ:EDIT – Get Free Report) are both small-cap medical companies,...
Critical Comparison: Auddia (NASDAQ:AUUD) and DoubleDown Interactive (NASDAQ:DDI)
DoubleDown Interactive (NASDAQ:DDI – Get Free Report) and Auddia (NASDAQ:AUUD – Get Free Report) are both small-cap consumer discretionary companies,...
StockNews.com Initiates Coverage on China Pharma (NYSE:CPHI)
StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHI – Free Report) in a report published on Thursday. The firm...